Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
OPERATING EXPENSES
General and administrative (net of insurance reimbursement of $0 and $1,250,000 during the three and nine months ended September 30, 2023 - See Note 5)	$ 4,619,519	$ 4,910,039	$ 6,983,670	$ 9,338,070
Research and development	1,495,619	2,805,103	4,022,020	9,404,980
Total operating expenses	6,115,138	7,715,142	11,005,690	18,743,050
Loss from operations	(6,115,138)	(7,715,142)	(11,005,690)	(18,743,050)
OTHER INCOME
Other income	120,640	73,252	377,891	79,443
Loss before income taxes	(5,994,498)	(7,641,890)	(10,627,799)	(18,663,607)
Income taxes
Net loss	$ (5,994,498)	$ (7,641,890)	$ (10,627,799)	$ (18,663,607)
Basic and diluted net loss per share (in Dollars per share)	$ (0.51)	$ (0.65)	$ (0.91)	$ (1.59)
Basic and diluted weighted average common stock outstanding (in Shares)	11,714,284	11,713,379	11,714,284	11,711,624